RENMYZE
Live / Allowed — First extension granted (statement of use) (as of 25 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99554451
- Mark type
- Word mark
- Filed
- 18 Dec 2025
- Published for opposition
- 10 Feb 2026
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders
Owner
- JOHNSON & JOHNSON, NEW BRUNSWICK, NJ, US
- JOHNSON & JOHNSON, NEW BRUNSWICK, NJ, US
Prosecution history
- 25 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2026 — SOU EXTENSION 1 GRANTED
- 25 Sept 2026 — SOU EXTENSION 1 FILED
- 25 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Apr 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jan 2026 — ASSIGNED TO EXAMINER
- 18 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 18 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Dec 2025 — NEW APPLICATION ENTERED